US Stock MarketDetailed Quotes

OM Outset Medical

Watchlist
  • 0.641
  • -0.027-3.98%
Trading Mar 4 10:32 ET
34.55MMarket Cap-0.26P/E (TTM)

Outset Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
11.47%-116.3M
32.54%-16.49M
39.50%-20.57M
-18.31%-33.34M
-2.58%-45.91M
9.85%-131.37M
29.17%-24.44M
0.91%-34M
26.96%-28.18M
-16.75%-44.76M
Net income from continuing operations
25.94%-127.98M
33.58%-25.64M
39.50%-27.94M
21.78%-34.45M
9.16%-39.94M
-6.04%-172.8M
6.86%-38.6M
-13.24%-46.18M
-0.47%-44.05M
-19.19%-43.97M
Operating gains losses
-50.00%53K
--19K
-15.38%11K
----
----
-92.46%106K
--0
--13K
----
----
Depreciation and amortization
-1.41%5.73M
-2.77%1.41M
-5.12%1.39M
-2.84%1.47M
5.49%1.46M
12.40%5.81M
13.95%1.45M
11.57%1.47M
14.35%1.51M
9.67%1.38M
Other non cash items
29.36%4.01M
30.51%1.05M
30.94%1.02M
27.28%989K
28.65%952K
107.29%3.1M
270.05%803K
84.16%779K
75.40%777K
79.61%740K
Change In working capital
-3,223.16%-25.69M
-47.60%2.08M
-145.10%-414K
-333.42%-11.9M
-43.55%-15.46M
96.34%-773K
207.31%3.98M
125.84%918K
210.92%5.1M
-15.95%-10.77M
-Change in receivables
1.61%-5.01M
-177.73%-1.92M
-110.26%-139K
120.19%544K
43.81%-3.5M
-103.27%-5.09M
144.23%2.47M
-35.93%1.36M
-219.09%-2.7M
-379.14%-6.22M
-Change in inventory
-759.20%-10.86M
322.08%2.13M
106.42%225K
-292.32%-6.23M
-342.99%-6.98M
111.18%1.65M
-132.41%-960K
-47.29%-3.51M
129.13%3.24M
168.67%2.87M
-Change in prepaid assets
6.09%784K
-455.85%-1.06M
186.24%652K
154.55%1.6M
-170.30%-400K
160.82%739K
115.39%299K
-214.89%-756K
1,035.82%627K
315.33%569K
-Change in payables and accrued expense
-4,137.08%-10.78M
57.51%2.6M
-108.41%-350K
-409.86%-7.64M
32.66%-5.4M
107.21%267K
416.25%1.65M
213.80%4.16M
-33.06%2.46M
-98.15%-8.01M
-Change in other current liabilities
-18.26%-1.59M
-9.09%-420K
-26.40%-407K
-18.35%-387K
-21.09%-379K
-17.13%-1.35M
-25.82%-385K
-8.78%-322K
-18.05%-327K
-15.50%-313K
-Change in other working capital
-41.33%1.77M
-16.32%754K
-2,368.75%-395K
-88.09%213K
251.03%1.2M
39.52%3.02M
6.50%901K
-260.00%-16K
92.37%1.79M
-9.07%341K
Cash from discontinued investing activities
Operating cash flow
11.47%-116.3M
32.54%-16.49M
39.50%-20.57M
-18.31%-33.34M
-2.58%-45.91M
9.85%-131.37M
29.17%-24.44M
0.91%-34M
26.96%-28.18M
-16.75%-44.76M
Investing cash flow
Cash flow from continuing investing activities
25.19%103.94M
361.70%108.15M
-46.74%15.88M
43.41%38.94M
-2,333.48%-59.03M
225.24%83.03M
145.27%23.43M
47.85%29.81M
2,163.30%27.15M
107.92%2.64M
Net PPE purchase and sale
73.49%-912K
95.92%-43K
49.49%-395K
84.91%-120K
56.30%-354K
58.68%-3.44M
50.07%-1.05M
71.47%-782K
60.19%-795K
45.20%-810K
Net investment purchase and sale
21.26%104.85M
342.01%108.2M
-46.81%16.27M
39.76%39.06M
-1,799.30%-58.68M
249.16%86.47M
149.31%24.48M
33.57%30.59M
4,003.96%27.95M
110.82%3.45M
Cash from discontinued investing activities
Investing cash flow
25.19%103.94M
361.70%108.15M
-46.74%15.88M
43.41%38.94M
-2,333.48%-59.03M
225.24%83.03M
145.27%23.43M
47.85%29.81M
2,163.30%27.15M
107.92%2.64M
Financing cash flow
Cash flow from continuing financing activities
55.48%67.87M
-102.82%-938K
-97.05%121K
-92.62%77K
1,200.17%68.61M
-40.12%43.65M
-49.35%33.23M
61.98%4.1M
0.10%1.04M
41.74%5.28M
Net issuance payments of debt
100.22%66.52M
--0
--0
--0
--66.52M
-48.77%33.23M
--33.23M
--0
--0
--0
Proceeds from stock option exercised by employees
-78.10%2.28M
--0
-97.05%121K
-92.62%77K
-60.47%2.09M
29.66%10.43M
-99.34%4K
53.79%4.1M
0.10%1.04M
41.74%5.28M
Net other financing activities
---938K
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
55.48%67.87M
-102.82%-938K
-97.05%121K
-92.62%77K
1,200.17%68.61M
-40.12%43.65M
-49.35%33.23M
61.98%4.1M
0.10%1.04M
41.74%5.28M
Net cash flow
Beginning cash position
-6.13%71.84M
-7.60%36.62M
3.70%41.19M
-10.56%35.51M
-6.13%71.84M
-64.51%76.53M
-59.23%39.63M
-63.50%39.72M
-73.12%39.7M
-64.51%76.53M
Current changes in cash
1,282.22%55.51M
181.66%90.73M
-4,924.18%-4.57M
28,315.00%5.68M
1.37%-36.33M
96.63%-4.7M
255.95%32.21M
99.22%-91K
100.05%20K
45.83%-36.84M
End cash Position
77.26%127.34M
77.26%127.34M
-7.60%36.62M
3.70%41.19M
-10.56%35.51M
-6.13%71.84M
-6.13%71.84M
-59.23%39.63M
-63.50%39.72M
-73.12%39.7M
Free cash flow
13.05%-117.22M
35.16%-16.53M
39.73%-20.96M
-15.48%-33.46M
-1.54%-46.27M
12.49%-134.81M
30.37%-25.5M
6.13%-34.78M
28.59%-28.97M
-14.45%-45.57M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 11.47%-116.3M32.54%-16.49M39.50%-20.57M-18.31%-33.34M-2.58%-45.91M9.85%-131.37M29.17%-24.44M0.91%-34M26.96%-28.18M-16.75%-44.76M
Net income from continuing operations 25.94%-127.98M33.58%-25.64M39.50%-27.94M21.78%-34.45M9.16%-39.94M-6.04%-172.8M6.86%-38.6M-13.24%-46.18M-0.47%-44.05M-19.19%-43.97M
Operating gains losses -50.00%53K--19K-15.38%11K---------92.46%106K--0--13K--------
Depreciation and amortization -1.41%5.73M-2.77%1.41M-5.12%1.39M-2.84%1.47M5.49%1.46M12.40%5.81M13.95%1.45M11.57%1.47M14.35%1.51M9.67%1.38M
Other non cash items 29.36%4.01M30.51%1.05M30.94%1.02M27.28%989K28.65%952K107.29%3.1M270.05%803K84.16%779K75.40%777K79.61%740K
Change In working capital -3,223.16%-25.69M-47.60%2.08M-145.10%-414K-333.42%-11.9M-43.55%-15.46M96.34%-773K207.31%3.98M125.84%918K210.92%5.1M-15.95%-10.77M
-Change in receivables 1.61%-5.01M-177.73%-1.92M-110.26%-139K120.19%544K43.81%-3.5M-103.27%-5.09M144.23%2.47M-35.93%1.36M-219.09%-2.7M-379.14%-6.22M
-Change in inventory -759.20%-10.86M322.08%2.13M106.42%225K-292.32%-6.23M-342.99%-6.98M111.18%1.65M-132.41%-960K-47.29%-3.51M129.13%3.24M168.67%2.87M
-Change in prepaid assets 6.09%784K-455.85%-1.06M186.24%652K154.55%1.6M-170.30%-400K160.82%739K115.39%299K-214.89%-756K1,035.82%627K315.33%569K
-Change in payables and accrued expense -4,137.08%-10.78M57.51%2.6M-108.41%-350K-409.86%-7.64M32.66%-5.4M107.21%267K416.25%1.65M213.80%4.16M-33.06%2.46M-98.15%-8.01M
-Change in other current liabilities -18.26%-1.59M-9.09%-420K-26.40%-407K-18.35%-387K-21.09%-379K-17.13%-1.35M-25.82%-385K-8.78%-322K-18.05%-327K-15.50%-313K
-Change in other working capital -41.33%1.77M-16.32%754K-2,368.75%-395K-88.09%213K251.03%1.2M39.52%3.02M6.50%901K-260.00%-16K92.37%1.79M-9.07%341K
Cash from discontinued investing activities
Operating cash flow 11.47%-116.3M32.54%-16.49M39.50%-20.57M-18.31%-33.34M-2.58%-45.91M9.85%-131.37M29.17%-24.44M0.91%-34M26.96%-28.18M-16.75%-44.76M
Investing cash flow
Cash flow from continuing investing activities 25.19%103.94M361.70%108.15M-46.74%15.88M43.41%38.94M-2,333.48%-59.03M225.24%83.03M145.27%23.43M47.85%29.81M2,163.30%27.15M107.92%2.64M
Net PPE purchase and sale 73.49%-912K95.92%-43K49.49%-395K84.91%-120K56.30%-354K58.68%-3.44M50.07%-1.05M71.47%-782K60.19%-795K45.20%-810K
Net investment purchase and sale 21.26%104.85M342.01%108.2M-46.81%16.27M39.76%39.06M-1,799.30%-58.68M249.16%86.47M149.31%24.48M33.57%30.59M4,003.96%27.95M110.82%3.45M
Cash from discontinued investing activities
Investing cash flow 25.19%103.94M361.70%108.15M-46.74%15.88M43.41%38.94M-2,333.48%-59.03M225.24%83.03M145.27%23.43M47.85%29.81M2,163.30%27.15M107.92%2.64M
Financing cash flow
Cash flow from continuing financing activities 55.48%67.87M-102.82%-938K-97.05%121K-92.62%77K1,200.17%68.61M-40.12%43.65M-49.35%33.23M61.98%4.1M0.10%1.04M41.74%5.28M
Net issuance payments of debt 100.22%66.52M--0--0--0--66.52M-48.77%33.23M--33.23M--0--0--0
Proceeds from stock option exercised by employees -78.10%2.28M--0-97.05%121K-92.62%77K-60.47%2.09M29.66%10.43M-99.34%4K53.79%4.1M0.10%1.04M41.74%5.28M
Net other financing activities ---938K------------------------------------
Cash from discontinued financing activities
Financing cash flow 55.48%67.87M-102.82%-938K-97.05%121K-92.62%77K1,200.17%68.61M-40.12%43.65M-49.35%33.23M61.98%4.1M0.10%1.04M41.74%5.28M
Net cash flow
Beginning cash position -6.13%71.84M-7.60%36.62M3.70%41.19M-10.56%35.51M-6.13%71.84M-64.51%76.53M-59.23%39.63M-63.50%39.72M-73.12%39.7M-64.51%76.53M
Current changes in cash 1,282.22%55.51M181.66%90.73M-4,924.18%-4.57M28,315.00%5.68M1.37%-36.33M96.63%-4.7M255.95%32.21M99.22%-91K100.05%20K45.83%-36.84M
End cash Position 77.26%127.34M77.26%127.34M-7.60%36.62M3.70%41.19M-10.56%35.51M-6.13%71.84M-6.13%71.84M-59.23%39.63M-63.50%39.72M-73.12%39.7M
Free cash flow 13.05%-117.22M35.16%-16.53M39.73%-20.96M-15.48%-33.46M-1.54%-46.27M12.49%-134.81M30.37%-25.5M6.13%-34.78M28.59%-28.97M-14.45%-45.57M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
D.R. Horton
DHI
+0.62%
Apple
AAPL
+0.56%
Alphabet-A
GOOGL
+0.59%
Alphabet-C
GOOG
+0.47%
KB Home
KBH
-0.08%

Unlock the Full List